Best Practice Database Supports Bio-Pharma Product Launch

Friday, September 12, 2008 General News J E 4
CHAPEL HILL, N.C., Sept. 11 Bio-Pharma executives areincreasingly finding value in the research products and services offered byBest Practices, LLC and in particular in use of the on-demand benchmarkrepository known as the Best Practice Database ( documents from the database may be accessed and downloadedindividually, many commercial and operations leaders have come to findoutstanding value in membership to the database which not only provides fullaccess to all content as needed, but also includes services such as newresearch alerts, invitations to participate in topical new studies and ongoingadvisory services to address research needs.

A series of six case study analogs recently published to the databasereview various aspects of product launch, providing unique perspectives forunderstanding the strategies and tactics utilized by top bio-pharma companiesto address commercial issues surrounding their products. One study, "CymbaltaCase Study: Successfully Entering a Crowded Market with a New Mechanism ofAction," reviews the strategy and tactics utilized by Eli Lilly for thedepression indicated product, Cymbalta, to successfully penetrate a crowdedmarket with a product having a new mechanism of action (MOA). Pharmaceuticalexecutives can use this study to gather insights into various tactics forsuccessfully launching a product with a new MOA into a challenging market.

For a complimentary summary from this case study, found in the BestPractice Database, "Cymbalta Case Study: Successfully Entering a CrowdedMarket with a New Mechanism of Action," click on the following link:

For more information on this study or the Best Practice Database, contactRobert Naylor at or (919) 767-9244. Interestedparties may sign-up for a customized tour of the database via the followingURL:


Best Practices, LLC, conducts work based on the simple yet profoundprinciple that organizations can chart a course to superior economicperformance by studying the best business practices, operating tactics andwinning strategies of world-class companies. For more than 15 years, ourhighly credentialed research staff has conducted primary research exclusivelyfor our Fortune 500 client base.Key topic areas in the research include: -- Business Challenges Addressed -- Market Entry Strategy and Insights -- Use of Third-Party Expertise -- Influencing Key Opinion Leaders -- Tactics to Drive Success -- Focus on Product Efficacy and Safety -- Product Differentiation -- Leveraging Public Relations -- Benefits of Patient Education -- Diversification of Tactics -- Early Lifecycle Management -- Crafting a Durable Brand Promise -- Preparing the Market Through Education Metrics included in this report are: -- Product Lifecycle Timeline -- Messaging Strategy -- PR Strategy -- Market Revenues Over Time -- Market DTC Expenditures

SOURCE Best Practices, LLC


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
IMRISneuro: The iMRI technology of choice among th...
Quintiles Recognized Among 'Best Companies to Work...